Tumour budding is a novel marker in breast cancer: the clinical application and future prospects

KEY MESSAGES: Currently, tumour budding is a poor prognosis for various solid tumours, also in breast cancer. Tumour budding is based on epithelial-mesenchymal transition and tumour microenvironment factors and is presumed to be an early step in the metastatic process. Breast cancer tumour budding s...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ting, Bao, Hui, Meng, Yu-hua, Zhu, Jian-lin, Chu, Xiao-dong, Chu, Xiao-li, Pan, Jing-hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103277/
https://www.ncbi.nlm.nih.gov/pubmed/35535687
http://dx.doi.org/10.1080/07853890.2022.2070272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103277/
https://www.ncbi.nlm.nih.gov/pubmed/35535687
http://dx.doi.org/10.1080/07853890.2022.2070272

Ejemplares similares